Some of that churn will be the loss of the OmniEarth business following purchase of the platform by EagleView. That being said the churn will need monitoring.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025